clopidogrel has been researched along with 4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, H; Chen, VM; Connor, D; Hogg, PJ; Kritharides, L; Lau, E; Lau, JK; Liang, HP; Muller, D; Pasalic, L; Pennings, GJ; Wing-Lun, E | 1 |
1 other study(ies) available for clopidogrel and 4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide
Article | Year |
---|---|
Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.
Topics: Aged; Arsenicals; Aspirin; Biomarkers; Blood Coagulation; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Drug Resistance; Female; Flow Cytometry; Glutathione; Humans; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests | 2018 |